ARTICLE | Distillery Therapeutics
Therapeutics: MAP kinase kinase 1 (MAP2K1; MEK1)
September 22, 2016 7:00 AM UTC
Mouse studies suggest activating MAP2K1-mediated signaling in oligodendrocytes could help treat CNS demyelination and nerve damage. In mice, oligodendrocyte-specific expression of constitutively activ...